| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |